These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33636736)

  • 41. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 42. [The significance of a large number of health insurance funds and fusions for health services research with statutory health insurance data in Germany - experiences of the lidA study].
    March S; Powietzka J; Stallmann C; Swart E
    Gesundheitswesen; 2015 Feb; 77(2):e32-6. PubMed ID: 25397909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Greece: Health system review.
    Economou C
    Health Syst Transit; 2010; 12(7):1-177, xv-xvi. PubMed ID: 21330233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Strength and weaknesses of the German digital health economy].
    Leppert F; Gerlach J; Ostwald DA; Greiner W
    Gesundheitswesen; 2018 Nov; 80(11):946-952. PubMed ID: 28746955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digitalizing Health Services by Implementing a Personal Electronic Health Record in Germany: Qualitative Analysis of Fundamental Prerequisites From the Perspective of Selected Experts.
    Pohlmann S; Kunz A; Ose D; Winkler EC; Brandner A; Poss-Doering R; Szecsenyi J; Wensing M
    J Med Internet Res; 2020 Jan; 22(1):e15102. PubMed ID: 32012060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential Benefits and Risks Resulting From the Introduction of Health Apps and Wearables Into the German Statutory Health Care System: Scoping Review.
    Heidel A; Hagist C
    JMIR Mhealth Uhealth; 2020 Sep; 8(9):e16444. PubMed ID: 32965231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Digital Therapeutic Care Apps With Decision-Support Interventions for People With Low Back Pain in Germany: Cost-Effectiveness Analysis.
    Lewkowicz D; Wohlbrandt AM; Bottinger E
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e35042. PubMed ID: 35129454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Strategic options for the relationship-management between hospital and statutory health insurance - an explorative study].
    Pick V; Rossbach C
    Gesundheitswesen; 2010 May; 72(5):279-84. PubMed ID: 19621279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Data protection and information security of digital health applications (DiGA)].
    Zilch A; Tschirsich M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1254-1261. PubMed ID: 34524475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of complementary and alternative medicine (CAM) in Germany - a focus group study of GPs.
    Joos S; Musselmann B; Miksch A; Rosemann T; Szecsenyi J
    BMC Health Serv Res; 2008 Jun; 8():127. PubMed ID: 18549476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [From idea to standard care-a field report].
    Herberz C; Steidl R; Werner P; Hagen J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):298-303. PubMed ID: 29383393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Five Key Questions for Health Services Research: are SHI Claims Data Suitable for Your Research Project?].
    Ihle P; Schneider U; Vogt V
    Gesundheitswesen; 2024 Jul; 86(S 03):S224-S230. PubMed ID: 37863050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The three-year evolution of Germany's Digital Therapeutics reimbursement program and its path forward.
    Schmidt L; Pawlitzki M; Renard BY; Meuth SG; Masanneck L
    NPJ Digit Med; 2024 May; 7(1):139. PubMed ID: 38789620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The new regulation to investigate potentially beneficial diagnostic and therapeutic methods in Germany: up to international standard?
    Olberg B; Perleth M; Busse R
    Health Policy; 2014 Aug; 117(2):135-45. PubMed ID: 24880719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Digital respiratory sleep medicine-part I: diagnosis].
    Schöbel C; Woehrle H
    Somnologie (Berl); 2020; 24(3):138-144. PubMed ID: 32904614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [ENT expert assessment for federal health insurance in North Rhine. A contribution to the internal discussion of quantitative and qualitative optimization of the expert witness process].
    Lauven G; Buszello HP; Müller-Held W
    Gesundheitswesen; 1999 Apr; 61(4):179-84. PubMed ID: 10408144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Digitized healthcare in 2030-a possible scenario].
    Brönneke JB; Hagen J; Kircher P; Matthies H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1285-1291. PubMed ID: 34533601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In search of a travel guide-results from a survey of E‑health startup companies].
    Hagen J; Lauer W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):291-297. PubMed ID: 29404630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.